FDA clears CTA313 (Car-T Cellular Therapy) trial for progressive MS, autoimmune disease
Basket study will test off-the-shelf CAR T-cell therapy in 3 conditions Written by Patricia Inacio, PhD | June 12, 2026 Imviva Biotech is cleared…
Categories
Latest Blog Posts
- Dysphagia – What causes it and how treated?
- Coping with Sudden MS Sweating When It’s Cold
- Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:
- Comprehensive Guide to Bladder Dysfunction in MS
- The Surprising Side Effect She Didn’t Dare Talk About
- Incidentalomas in Multiple Sclerosis
- How to Treat MS Pain
- Wheelchair Fit for Function and Support
- Scientists Find New Evidence Linking Epstein-Barr Virus to MS
- MS Study Alert: How Can We Prevent Falls in People Who Use Wheelchairs? Researchers Recruiting for Two Studies
- New Study Points to Racial and Ethnic Differences in MS-Related Deaths
- For Your Loved Ones
- Heat Sensitivity With Multiple Sclerosis
- Driving rehabilitation program
- Top 5 Ways to Relieve OsteoArthritis Pain
- Top 5 Ways to Relieve Arthritis Pain
- B-Cell Depletion Recruits Protective Gut Cells in MS
- What Is the Nordic Diet? A Detailed Beginner’s Guide
- MS Flare vs. Pseudo-Relapse: How Heat, Infection, and Stress Can Mimic a Relapse
- Nasal MS therapy moves closer to results after final patient dosed
